Guided Therapeutics, Inc.
GTHP
$0.0831
-$0.0059-6.63%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -72.73% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -72.73% | -- | -- |
| Cost of Revenue | -- | -- | -77.78% | -79.75% | -- |
| Gross Profit | -- | -- | -69.23% | 120.25% | -233.33% |
| SG&A Expenses | -18.18% | -70.14% | -63.60% | -50.00% | -54.88% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -9.95% | -57.71% | -57.80% | -45.46% | -49.23% |
| Operating Income | 9.95% | 56.48% | 57.41% | 48.84% | 49.10% |
| Income Before Tax | 3.40% | 54.46% | 53.74% | 78.64% | 38.57% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 3.40% | 54.46% | 53.74% | 78.64% | 38.57% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.40% | 54.46% | 53.74% | 78.64% | 38.57% |
| EBIT | 9.95% | 56.48% | 57.41% | 48.84% | 49.10% |
| EBITDA | 9.98% | 56.59% | 57.55% | 48.89% | 49.25% |
| EPS Basic | 12.95% | 57.14% | 58.88% | 77.00% | 54.13% |
| Normalized Basic EPS | 13.10% | 58.03% | 58.26% | 52.71% | 65.85% |
| EPS Diluted | 12.95% | 57.14% | 50.00% | 77.12% | 54.13% |
| Normalized Diluted EPS | 13.10% | 58.03% | 58.26% | 52.71% | 65.85% |
| Average Basic Shares Outstanding | 10.81% | 9.84% | 11.06% | 9.88% | 47.79% |
| Average Diluted Shares Outstanding | 10.81% | 9.84% | 11.06% | 9.88% | 47.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
